Yan Xiang Selected Research

dihydrosanguinarine

8/2022

Dihydrosanguinarine based RNA-seq approach couple with network pharmacology attenuates LPS-induced inflammation through TNF/IL-17/PI3K/AKT pathways in mice liver.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan Xiang Research Topics

Disease

13	Neoplasms (Cancer) 01/2022 - 07/2011
11	Infections 04/2021 - 02/2003
7	Glioma (Gliomas) 11/2021 - 01/2016
6	Brain Ischemia (Cerebral Ischemia) 01/2022 - 07/2018
5	Inflammation (Inflammations) 08/2022 - 12/2008
4	Brain Diseases (Brain Disorder) 01/2022 - 01/2020
4	Reperfusion Injury 01/2022 - 01/2020
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 07/2018
4	COVID-19 12/2021 - 07/2020
4	Virus Diseases (Viral Diseases) 01/2021 - 09/2006
4	Cicatrix (Scar) 12/2019 - 04/2006
4	Smallpox (Variola) 05/2016 - 01/2011
3	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 07/2020
3	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 06/2006
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2021 - 02/2017
2	Pain (Aches) 01/2020 - 11/2017
2	Low Back Pain (Lumbago) 01/2020 - 01/2018
2	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2018 - 07/2008
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 01/2018
2	Burns 11/2017 - 04/2006
2	Vaccinia 01/2017 - 11/2009
2	Carcinogenesis 06/2015 - 09/2007
2	Lymphoma (Lymphomas) 12/2012 - 09/2007
2	Communicable Diseases (Infectious Diseases) 08/2012 - 07/2011
1	Myopia 01/2022
1	Hyperopia (Hypermetropia) 01/2022
1	Cross Infection (Nosocomial Infection) 01/2022
1	Amastia 10/2021
1	Vision Disorders (Hemeralopia) 07/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Asthma (Bronchial Asthma) 01/2020
1	Respiratory Hypersensitivity 01/2020
1	Lung Injury 01/2020
1	Acute Lung Injury 01/2020
1	Multiple Myeloma 12/2019
1	Multiple Organ Failure (MODS) 10/2018

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 11/2021 - 09/2006
7	Antiviral Agents (Antivirals)IBA 01/2022 - 09/2006
6	Liposomes (Liposome)IBA 01/2022 - 07/2018
5	baicalinIBA 01/2022 - 07/2018
5	Pharmaceutical PreparationsIBA 12/2021 - 12/2010
5	CytokinesIBA 01/2017 - 09/2006
4	RNA (Ribonucleic Acid)IBA 08/2022 - 01/2020
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
4	CollagenIBA 03/2020 - 04/2006
4	Interleukin-18 (Interleukin 18)IBA 01/2017 - 02/2003
4	VaccinesIBA 10/2014 - 01/2011
3	EpitopesIBA 05/2016 - 03/2008
2	hydrogen sulfite (bisulfite)IBA 01/2022 - 01/2018
2	Therapeutic UsesIBA 01/2022 - 01/2020
2	Yi Guan Jian DecoctionIBA 11/2021 - 02/2017
2	Fluorescein (Funduscein)FDA LinkGeneric 09/2021 - 04/2018
2	Claudin-5IBA 09/2021 - 04/2018
2	Neuroprotective AgentsIBA 08/2021 - 01/2020
2	AntibodiesIBA 01/2021 - 05/2016
2	Long Noncoding RNAIBA 07/2020 - 01/2018
2	LipopolysaccharidesIBA 06/2020 - 01/2020
2	salicylhydroxamic acid (SHAM)IBA 01/2020 - 01/2018
2	Temozolomide (Temodar)FDA LinkGeneric 12/2019 - 01/2016
2	LuciferasesIBA 01/2018 - 01/2017
2	AlkaliesIBA 11/2017 - 04/2006
2	InterferonsIBA 01/2015 - 09/2006
1	dihydrosanguinarineIBA 08/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	sortilinIBA 11/2021
1	CateninsIBA 11/2021
1	geniposideIBA 08/2021
1	NucleotidesIBA 04/2021
1	remdesivirIBA 04/2021
1	ChemokinesIBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	ProteomeIBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 07/2020
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 07/2020
1	Messenger RNA (mRNA)IBA 07/2020
1	FlavonoidsIBA 06/2020
1	AlkaloidsIBA 06/2020
1	Interleukin-33IBA 01/2020
1	isoborneol (borneol)IBA 01/2020
1	AllergensIBA 01/2020
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 12/2019
1	BromidesIBA 12/2019
1	SurvivinIBA 12/2019
1	Bortezomib (Velcade)FDA Link 12/2019
1	Proteasome InhibitorsIBA 12/2019
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 10/2018
1	CD40 Ligand (CD40L)IBA 10/2018
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2018

Therapy/Procedure

9	Therapeutics 08/2021 - 06/2006
4	Drug Therapy (Chemotherapy) 12/2019 - 08/2014
2	Intranasal Administration 01/2020 - 01/2020
2	Lasers (Laser) 01/2010 - 01/2010
2	Trabeculectomy (Trabeculoplasty) 01/2010 - 01/2010
1	Ambulatory Surgical Procedures (Outpatient Surgery) 01/2022
1	Transplantation 11/2021
1	Decompression 07/2021
1	Acupuncture Therapy 01/2020
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020
1	Aftercare (After-Treatment) 01/2020